
                     
                     
                     Drug Interactions
                     
                        The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.
                        In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.
                        Butalbital, Aspirin, and Caffeine Capsules, USP may enhance the effects of:
                        Butalbital, Aspirin, and Caffeine Capsules, USP may diminish the effects of:
                        Uricosuric agents such as probenecid and sulfinpyrazone, reducing their effectiveness in the treatment of gout. Aspirin competes with these agents for protein binding sites.
                     
                     
                  
               